CollPlant Biotechnologies (CLGN) Prepaid Assets (2018 - 2026)
CollPlant Biotechnologies (CLGN) reported Prepaid Assets of $225000.0 for Q1 2026, down 99.95% on a YoY basis from $440.0 million in Q1 2025, and up 0.9% quarter-over-quarter from $223000.0 in Q4 2025.
CollPlant Biotechnologies (CLGN) Prepaid Assets (2018 - 2026) Analysis & Trends
CollPlant Biotechnologies has reported Prepaid Assets for 9 years, with the latest figure at $225000.0 in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 99.95% year-over-year to $225000.0; the trailing twelve-month figure through Mar 2026 stood at $225000.0 (down 99.95% YoY), and the FY2025 full-year result was $223000.0, down 99.95% from the prior year.
- Prepaid Assets for Q1 2026 stood at $225000.0, up from $223000.0 in the prior quarter.
- The five-year high for Prepaid Assets was $543.0 million in Q4 2022, with the low at $223000.0 in Q4 2025.
- Historically, Prepaid Assets has averaged $163.6 million across 5 years, with a median of $542000.0 in 2022.
- Annual changes were most pronounced in 2024 — Prepaid Assets soared 110078.12% — and 2026, when it plunged 99.95%.
- CollPlant Biotechnologies' Prepaid Assets stood at $543.0 million in 2022, then plunged by 99.93% to $393000.0 in 2023, then soared by 110078.12% to $433.0 million in 2024, then slumped by 99.95% to $223000.0 in 2025, then gained by 0.9% to $225000.0 in 2026.
- The last three Prepaid Assets figures came in at $225000.0 (Q1 2026), $223000.0 (Q4 2025), and $364000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 225,000.00 |
| Dec 31, 2025 | 223,000.00 |
| Jun 30, 2025 | 364,000.00 |
| Mar 31, 2025 | 440.00 Mn |
| Dec 31, 2024 | 433.00 Mn |
| Sep 30, 2024 | 426.00 Mn |
| Jun 30, 2024 | 490,000.00 |
| Mar 31, 2024 | 279.00 Mn |
| Dec 31, 2023 | 393,000.00 |
| Sep 30, 2023 | 493.00 Mn |
| Jun 30, 2023 | 758,000.00 |
| Mar 31, 2023 | 408,000.00 |
| Dec 31, 2022 | 543.00 Mn |
| Sep 30, 2022 | 489,000.00 |
| Jun 30, 2022 | 594,000.00 |
| Mar 31, 2022 | 263,000.00 |
| Dec 31, 2021 | 424.00 Bn |
| Sep 30, 2021 | 743,000.00 |
| Jun 30, 2021 | 979,000.00 |
| Mar 31, 2021 | 267.00 Mn |